Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer

NCT03405142 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Head and Neck Cancer

Interventions

DRUG: Panitumumab-IRDye800
DRUG: Lymphoseek

Sponsor

Eben Rosenthal

Collaborators

[object Object]